For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $413.65 in the prior trading day, Elevance Health Inc (NYSE: ELV) closed at $420.58, up 1.68%. In other words, the price has increased by $1.68 from its previous closing price. On the day, 1.36 million shares were traded. ELV stock price reached its highest trading level at $422.215 during the session, while it also had its lowest trading level at $412.44.
Ratios:
Our goal is to gain a better understanding of ELV by taking a closer look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.71 whereas as Long-Term Debt/Eq ratio is at 0.66.
On March 17, 2025, Argus Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $450.
Stephens Downgraded its Overweight to Equal-Weight on January 22, 2025, whereas the target price for the stock was revised from $520 to $440.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 24 ’25 when Kaye Mark sold 4,588 shares for $424.82 per share. The transaction valued at 1,949,074 led to the insider holds 18,977 shares of the business.
Kaye Mark bought 4,588 shares of ELV for $1,949,051 on Apr 24 ’25. On Mar 10 ’25, another insider, Penczek Ronald W, who serves as the CAO & Controller of the company, sold 443 shares for $415.13 each. As a result, the insider received 183,903 and left with 1,847 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELV now has a Market Capitalization of 95023742976 and an Enterprise Value of 91491573760. As of this moment, Elevance’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.41, and their Forward P/E ratio for the next fiscal year is 10.72. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.53. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.52 while its Price-to-Book (P/B) ratio in mrq is 2.23. Its current Enterprise Value per Revenue stands at 0.5 whereas that against EBITDA is 9.303.
Stock Price History:
The Beta on a monthly basis for ELV is 0.67, which has changed by -0.19982499 over the last 52 weeks, in comparison to a change of 0.09969199 over the same period for the S&P500. Over the past 52 weeks, ELV has reached a high of $567.26, while it has fallen to a 52-week low of $362.21. The 50-Day Moving Average of the stock is 0.38%, while the 200-Day Moving Average is calculated to be -5.77%.
Shares Statistics:
The stock has traded on average 1.68M shares per day over the past 3-months and 1777740 shares per day over the last 10 days, according to various share statistics. A total of 225.64M shares are outstanding, with a floating share count of 225.49M. Insiders hold about 0.20% of the company’s shares, while institutions hold 93.37% stake in the company. Shares short for ELV as of 1744675200 were 3058842 with a Short Ratio of 1.82, compared to 1741910400 on 2523417. Therefore, it implies a Short% of Shares Outstanding of 3058842 and a Short% of Float of 1.3599999999999999.
Dividends & Splits
In the trailing 12 months, ELV’s forward annual dividend rate was 6.6, compared to 6.60 this year. Against a Trailing Annual Dividend Yield of 0.015955517The stock’s 5-year Average Dividend Yield is 1.18. The current Payout Ratio is 25.39% for ELV, which recently paid a dividend on 2025-03-10 with an ex-dividend date of 1749513600. Stock splits for the company last occurred on 2005-06-01 when the company split stock in a 2:1 ratio.
